NCT01827917View on ClinicalTrials.gov

The Protection Effect of Speeda® Rabies Vaccine for Human Use

PHASE4CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2014

Conditions
Rabies Vaccine Allergy
Interventions
BIOLOGICAL

rabies vaccine

Injection on day 0、7、21

Trial Locations (1)

Unknown

Hunan Centers for Disease Control and Prevention, Changsha

All Listed Sponsors
lead

Beijing Center for Disease Control and Prevention

OTHER_GOV

NCT01827917 - The Protection Effect of Speeda® Rabies Vaccine for Human Use | Biotech Hunter | Biotech Hunter